Avacta Life Sciences Limited
  • About
  • Therapeutics
  • Diagnostics
  • Investors
  • News
  • Careers
  • Contact
  • About
    • About Avacta
    • Group Team
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • preCISIONTM
    • Affimer®
    • Pipeline
    • Partners
    • Clinical trials
    • Team
    • News
  • Diagnostics
    • Diagnostics
    • Our Brands
    • Affimer®
    • Team
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Research
  • News
  • Careers
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Group Team
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • preCISIONTM
    • Affimer®
    • Pipeline
    • Partners
    • Clinical trials
    • Team
    • News
  • Diagnostics
    • Diagnostics
    • Our Brands
    • Affimer®
    • Team
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Research
  • News
  • Careers
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
Home News Blogs
filter by: view all | Blogs | Diagnostics | Investors | Therapeutics

Blogs

08 Mar 2023

Interview with Victoria Statham, VP Intellectual Property & Legal, Therapeutics

Blogs
19 Jan 2022

‘Diagnosing Emerging Variants of SARS-CoV-2 for Effective Transmission Control’ article published in European Biopharmaceutical Review January 2022

Blogs
16 Nov 2021

New Paper: Clinical evaluation of AffiDX® SARS-CoV-2 Antigen Lateral Flow Test

Blogs | Diagnostics
03 Nov 2021

Interview with Fiona McLaughlin – Avacta Chief Scientific Officer, Therapeutics

Blogs | Therapeutics
15 Sep 2021

Lateral Flow Assay Testing for COVID-19 – Tackling asymptomatic spread

Blogs | Diagnostics
24 Mar 2021

Life at Avacta: Interview with Carol Greenlees, Head of Clinical Operations

Blogs
30 Jul 2020

Innovations in neutralising therapies

Blogs | Therapeutics
25 Jun 2020

Responding to disease outbreaks – the importance of point-of-care diagnostics

Blogs | Diagnostics
19 Jun 2020

European Biopharmaceutical Review COVID-19 diagnostics article

Blogs | Diagnostics
18 May 2020

Lab testing vs point of care – how both should be combined to provide full support to communities

Blogs | Diagnostics

Posts navigation

Older posts
Avacta Life Sciences Limited
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Returns & cancellations policy
  • Corporate Responsibility
  • Contact Us

Avacta Diagnostics

Unit 20, Ash Way
Thorp Arch Estate
Wetherby
LS23 7FA
+44 (0)1904 21 7070

virtual tour
email

Avacta Therapeutics

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3871 9700

Investor Enquiries

Consilium
Strategic Communications
85 Gresham Street
London
EC2V 7NQ

Email

Twitter | Linkedin

©2023 Avacta Life Sciences Limited. Registered company no. 06605196.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok